-5%
- Treatment of duodenal and gastric ulcers.
- Gastric and duodenal ulcers caused by NSAIDs.
- Management of Gastroesophageal Reflux Disease (GERD).
- H. pylori eradication using appropriate antibiotics.
- Zollinger-Ellison Syndrome.
- Treatment of conditions caused by excessive stomach acid production.
- Conditions include erosive esophagitis, GERD, H. pylori infection, and Zollinger-Ellison syndrome.
- Short-term treatment (4-8 weeks) of severe erosive esophagitis.
- Short-term treatment of GERD is poorly responsive to customary medical treatment.
- Heartburn and GERD symptoms.
- Pathological hypersecretory conditions.
- Peptic ulcer disease and gastric ulcer therapy.
- Maintenance of healing of erosive esophagitis.
- Combination use in H. pylori eradication for active duodenal ulcer prevention.
- Belongs to proton pump inhibitors, blocking the proton pump in stomach cells, and reducing acid production.
- Determined by the doctor based on age, condition severity, medical history, and body response.
- Availability: delayed-release capsule or liquid suspension.
- Processed by the liver; caution in chronic liver disease.
- Potential transfer to the child through breastfeeding; consult a doctor if pregnant or breastfeeding.